HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Infectious Disease
Meta-analysis
All-oral MDR-TB regimens achieve 91% treatment success in children and adolescents
Newer TB Drugs Help Most Children With Drug-Resistant TB
This meta-analysis of 490 children and adolescents with MDR-TB, XDR-TB, or rifampicin-resistant TB found 89% pooled treatment success (95% C…
In a global analysis of 490 children with drug-resistant TB, newer all-oral regimens worked in 91% of cases, beating older injectable regime…
Nov 4, 2026
Infectious Disease
RCT
6-month bedaquiline, linezolid, delamanid, and levofloxacin or clofazimine regimen is noninferior to 9-month standard care
Trial shows shorter treatment works for resistant tuberculosis
This Phase 3 randomized controlled noninferiority trial evaluated a 6-month treatment strategy for pulmonary rifampicin-resistant tuberculos…
A new six-month treatment plan for drug-resistant tuberculosis showed similar success rates to the standard nine-month course.
Jun 25, 2026